The largest database of trusted experimental protocols

14 protocols using pfuse higg1 fc2

1

Production of PDL1-scFv-Fc-RE7 Fusion Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
We utilized a cloning strategy that was described previously [13 (link)]. In short, the Atezolizumab PDL1-scFv sequence was obtained from the publication of Lee et al. [8 (link)] and synthesized by GeneScript (Piscataway, NJ). PDL1-scFv was cloned into EcoRI/Bgl II sites of pFUSE-hIgG1-Fc2 purchased from InvivoGen (San Diego, CA). To generate PDL1-scFv-Fc-RE7, the DNA fragment encoding the DNA furin cleavage site (RVKR) linked to the E7 peptide (amino acid 49-57, RAHYNIVTF) was generated using oligos CTAGAAGGGTGAAGAGACGCGCTCACTACAACATCGTGACCTTTTAAC and TCGAGTTAAAAGGTCACGATGTTGTAGTGAGCGCGTCTCTTCACCCTT, which were then annealed and cloned into XbalI/Xho sites of PDL1-scFv-Fc.
+ Open protocol
+ Expand
2

MERS-CoV Spike Protein Recombinant RBD

Check if the same lab product or an alternative is used in the 5 most similar protocols
The recombinant RBD protein, S377–588-Fc, was selected to test the effects of the above adjuvants. The construction, expression and purification of S377–588-Fc were described previously.15 (link) Briefly, codon-optimized genes encoding residues 377–588 of MERS-CoV spike protein were fused with Fc of human IgG (pFUSE-hIgG1-Fc2; InvivoGen). The resultant protein was expressed in 293 T-cell culture supernatant and purified by protein A affinity chromatography (GE Healthcare, Piscataway, NJ, USA). The ELISA coating antigen, MERS-CoV S1 protein (residues 18–725) plus a C-terminal His6 (S1-His), was constructed using a pJW4303 expression vector (Jiangsu Taizhou Haiyuan Protein Biotech, Co., Ltd, Taizhou, China), expressed in 293 T-cell culture supernatant, and purified using Ni-NTA Superflow (Qiagen, Valencia, CA, USA).
+ Open protocol
+ Expand
3

Production of Nanobody-Fc Fusion Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
The nanobody A6 and a13 sequences were subcloned to pFUSE-hIgG1-Fc2 (InvivoGen, San Diego, CA, USA), which was modified to insert a 6xHis-tag at the C-terminal of the Fc domain, to produce a nanobody–human IgG1 Fc fusion antibody (Nanobody-hFc). An Fc-enhanced A6 antibody was constructed to include two mutations in the Fc domain, specifically serine (S) at residue 239 to aspartic acid (D), and isoleucine (I) at position 332 to glutamic acid (E). This mutant was named A6-hFc-SDIE. The nanobody-hFc was produced by an Expi293F transient expression system (Thermo Fisher, Walthem, MA, USA) as described above for recombinant B7-H3. Samples were purified using TALON resin (Takara Bio, Dalian, China) and polished by size exclusion chromatography (Superdex 200 10/300 GL). Purified antibodies were concentrated and buffer exchanged to PBS.
+ Open protocol
+ Expand
4

Plasmid Cloning and Reporter Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Full-length human LRP6, ICAM-1, or EphA2 cDNA cloned into pCMV-Entry (Origene) were used for sub-cloning or transient transfection. pFUSE-hIgG1-Fc2 (InvivoGen) was used for Fc-fusion constructs of truncated LRP6E1E2 and LRP6E3E4 domains. For bispecific tandem scFv-Fc constructs, pFUSE-hIgG1-Fc2 vector was modified by inserting a (G4S)5 linker between two scFv fusions. IgG-Abvec plasmids (Ig-γ and Ig-λ) were kindly provided by Dr. Patrick Wilson at University of Chicago56 (link). The β-catenin-responsive luciferase reporter SuperTopFlash (STF) and the internal control pRL-SV40 Renilla luciferase constructs (Addgene) were used for STF reporter assays. To provide Wnt ligands in STF reporter assays, pcDNA-Wnt1 or -Wnt3a expression plasmid (Addgene) was utilized for transient transfections.
+ Open protocol
+ Expand
5

Recombinant M25 Antibody Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
To generate M25 scFv-Fc and M25 full-length human IgG1, M25 scFv was subcloned into either the Fc fusion expression vector pFUSE-hIgG1 Fc2 (InvivoGen) or a modified Abvec expression vector that was originally provided by Dr. Patrick Wilson (17 (link)), respectively. The antibodies were transiently expressed in HEK 293A cells following polyethylenimine (Sigma-Aldrich) transfection (18 (link),19 ). The secreted antibody in serum-free DMEM containing Nutridoma-SP (Sigma) and penicillin-streptomycin were harvested 5 days post transfection, filtered by 0.22 μm filter (Millipore), and purified using protein A agarose (Pierce/Thermo Fisher Scientific). Antibody concentrations were determined using nanodrop 2000 (Thermo Fisher Scientific).
+ Open protocol
+ Expand
6

VH Domain Antibody Fusion Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rabbit VH domain antibodies were fused with His-FLAG tag, inserted into the expression vector pFUSE-hIgG1-Fc2 (pfuse-hg1fc2; InvivoGen), and expressed as a VH-His-FLAG-hFc format in 293F cells according to the aforementioned method. The 6× His tag was used for Nickel column affinity purification and the hFc tag was used in the cell binding assay by flow cytometry that used goat anti-human polyclonal antibody (cat. no. 109-135-170, Jackson ImmunoResearch Laboratories, Inc.) as secondary antibody.
+ Open protocol
+ Expand
7

SARS-CoV-2 RBD Protein Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
The codon-optimized SARS-CoV-2 rbd gene (N334 –K529, accession No. QHD43416.1) with (G4S)3-linker was synthesized (Twist Bioscience, USA) and inserted into pFUSE-hIgG1-Fc2 (InvivoGen, USA) at EcoRI and BglII restriction sites. The insert was located between IL2 signal sequence and human IgG1 Fc gene. The expression plasmid amplified in E. coli was extracted for transfection using QIAGEN Plasmid Maxi Kit (Qiagen, Germany). DNA concentration and quality were measured and assessed using Nanodrop One microvolume UV-Vis Spectrophotometer (Thermo Fisher Scientific, USA).
+ Open protocol
+ Expand
8

NLRR1 Protein Expression and Engineering

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human NLRR1 (NM_020873) tagged with HA at the C-terminal was cloned into the BamHI/NotI site of pcDNA3.1-myc-His (Invitrogen). This construct was used to generate other NLRR1-related plasmids. For secretion of the intact NLRR1 ectodomain, the corresponding PCR-amplified fragment of the intact extracellular region (exN1: M1-L632) was inserted into the BamHI/XhoI site of the pSecTag2B vector (Invitrogen). To fuse exN1 with human placental alkaline phosphatase (AP: NM_001632), the PCR fragment of AP (I18-G489) were inserted into the C-terminal of the pSecTag2B-exN1 vector using the In-Fusion cloning technique (Clontech). To generate the Fc chimeric proteins, intact exN1 and its deletion mutants (exN1-Fc: M1-L632; ΔLRR-Fc: N362-L632; ΔL-Ig-Fc: V516-L632) were introduced into the EcoRI site of pFUSE-hIgG1-Fc2 (Invivogen). The pEGFP-N1 plasmid was employed for EGFP-expressing cells. Expression vectors for WT ALK and ALK F1174L were kind gifts from Dr. Junko Takita (The University of Tokyo, Tokyo, Japan). The ALK R1275Q construct was generated using site-directed mutagenesis. Mission short hairpin RNA constructs, NM_020873.3-427s1c1, NM_020873.3-846s1c1, and NM_020873.3-1359s1c1, were purchased from Sigma.
+ Open protocol
+ Expand
9

Engineering Peptide-Fc Fusion Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following overlapping DNA oligonucleotides encoding peptides were made and HPLC purified by Eurofins Genomics (Ebersberg, Germany).
WN-Fc-1 peptide (WNLPWYYSVSPT) 5′-aattcgtggaatcttccttggtattatagcgtcagtcctacgggtggaggca-3′ 5′-gatctgcctccacccgtaggactgacgctataataccaaggaagattccacg-3′ WN-Fc-2 peptide (WNLPWYYSVSPTGGGWNLPWYYSVSPT) 5′-aattcgtggaatcttccttggtattatagcgtcagtcctacgggtggaggctggaa tcttccttggtattatagcgtcagtcctacgggtggaggca-3′ 5′-gatctgcctc cacccgtaggactgacgctataataccaaggaagattccagcctccacccgtagga ctgacgctataataccaaggaagattccacg-3′ Fc control peptide (ISAMVRS) 5′-aattcgatatcggccatggtta-3′ 5′-aattcgatatcggcc atggtta-3′
DNA oligonucleotides were annealed together to form a double stranded sequence with overhanging bases for EcoR1 and BglII restriction sites and then cloned into EcoR1-BglII-cleaved pFuse-hIgG1-Fc2 vector in frame with IL-2 signal sequence and the Fc portion of human IgG1 (In vivoGen, San Diego, CA, USA). Recombinant peptide Fc fusion proteins were produced by transient transfection of the plasmids into HEK293T cells and purified by protein G chromatography. Protein purity was determined by electrophoresis on 10% sodium dodecyl sulfate (SDS) polyacrylamide gel and positive fractions were collected, pH adjusted to 7.5 and then stored at −80°C until use.
+ Open protocol
+ Expand
10

Generation of Fc-fusion Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
The generation of Fc-fusion proteins for mouse Clec7A, mouse Clec12A, and human Clec12A has been previously described (24 (link)). For murine MARCO (NCBI: NP_034896.1, aa: 83-518) and human MARCO (NCBI: NP_006761.1, aa: 79-520), the cDNA of the extracellular domains (Origene, #MR222739 and #RC205625, respectively) were amplified by PCR and verified by restriction digest. Primers used in 5’-3’ direction: mMARCO forward = ATGTGCTGTGGCAATGGATC and reverse = GGAGCATTCCACACCCG; hMARCO forward = ATGTATTTCCTCAATGACACTCTG and reverse = GACGCTGCACTCCACG. The cDNAs were fused to the C-terminus of human IgG1-Fc in the expression vector pFUSE-hIgG1-Fc2 (InvivoGen, #pfuse-hg1fc2). After sequence verification, constructs were transfected into 293T cells (DSMZ, #ACC 635) using PolyJet Transfection Reagent as described above. Supernatants were harvested 48 and 72 h post transfection, pooled, sterile filtered, and stored at 4°C until usage as a source of recombinant proteins. Correct protein secretion was verified by Western blot analysis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!